- Home
- NUVO
as 07-26-2024 4:00pm EST
Holdco Nuvo Group DG Ltd is a women's health and connected pregnancy care company and has developed INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform that enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring, helping expectant mothers adhere to their prescribed care plan. INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every participant involved in pregnancy care.
| Founded: | 1990 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 39.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 71.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.63 - $21.50 | Next Earning Date: | 08-26-2024 |
| Revenue: | $176,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Holdco Nuvo Group D.G Ltd. Ordinary Shares News
NUVO Breaking Stock News: Dive into NUVO Ticker-Specific Updates for Smart Investing
Compare NUVO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NUVO Holdco Nuvo Group D.G Ltd. Ordinary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.